Home / Health / Babies to Get New SMA Blood Test
Babies to Get New SMA Blood Test
27 Aug
Summary
- Newborns to be tested for Spinal Muscular Atrophy (SMA) starting October.
- A five-year study will assess SMA testing's effectiveness for the NHS.
- The trial, led by Oxford, begins nationally after a phased rollout.
A groundbreaking five-year study commencing this October will introduce universal testing for Spinal Muscular Atrophy (SMA) in newborn babies across the UK. Professor Laurent Servais of the University of Oxford is leading the investigation to evaluate the viability of adding SMA screening to the standard newborn blood spot test.
The trial, spearheaded by Oxford's Department of Paediatrics, will initially roll out in Birmingham, Manchester, and London. Following this phased introduction, the national program is scheduled to launch from October 2027. This initiative responds to growing calls for broader SMA testing.
Campaigns advocating for this change have highlighted the critical importance of early detection for conditions like SMA. The study's findings will be crucial in determining the long-term integration of SMA screening into the National Health Service, impacting future public health strategies for rare diseases.
